Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
/PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of...
Source: prnewswire.com